Vijaya Diagnostic Centre
Other · 2 quarters tracked · source-linked performance and management context.
Latest revenue
₹219 Cr
verified financial record
Quarters tracked
2
source records in the directory
Delivery assessment
0
Across 1 tracked commitments: 0 delivered, 1 missed.
Call date
2026-05-15
latest available source date
Signal trajectory
2 actual quartersCurrent read
0/100
Across 1 tracked commitments: 0 delivered, 1 missed.
Latest source read
What changed this quarter?
Vijaya Diagnostic delivered a strong Q4 FY26 with revenue of ₹219 crore (+26.6% YoY) and EBITDA margin of 43.5% (+379bps YoY), driven by 18.5% volume growth and favorable seasonality. The wellness segment and Hyderabad market (20% growth) were key contributors. PAT stood at ₹47.9 crore (+37.5% YoY). Management guided for 40%+ EBITDA margins in FY27 despite new center investments, with capex of ₹140-150 crore for 4-5 hubs and 10-12 spokes. The automated lab in Punjagutta and genomic testing are new initiatives. Risk: competitive intensity from hospital labs and online aggregators could pressure pricing and market share.
Colored figures compare against the previous available record. Hover or focus one for the comparison.
Signal
Positive
Revenue
₹219 Cr
Source date
2026-05-15
Across the record
Quarter history.
History modules